Vertex Pharmaceu (VRTX)
$472.76
1.74 (0.37%)
VRTX Stock Quote Delayed 30 Minutes
Biggest Movers in Healthcare Stocks Now – WCG CMN IRWD IPXL
Healthcare stocks finished down on Wall Street on Thursday, down 0.2%. NYSE:WCG, NYSE:CMN, NASDAQ:IRWD, NASDAQ:IPXL, NASDAQ:MGLN, NYSE:STJ, NASDAQ:PRXL, NYSE:OPK, NYSE:CHE, NYSE:COO, NYSE:HLS, NASDAQ:WOOF, NYSE:MSA, NYSE:TEVA, NASDAQ:MWIV, NYSE:LLY, NYSE:DGX, NASDAQ:PODD, NASDAQ:NPSP, NASDAQ:VRTX
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$479.10
Market Cap
123.03B
PE Ratio
-227.66
EPS
-2.0766
Volume (Avg. Vol.)
950,967
Day's Range
$473.51 - $486.07
52-Week Range
$377.85 - $519.88
Dividend & Yield
N/A (N/A)
VRTX Stock Predictions, Articles, and Vertex Pharmaceu News
50 Ways to Make Market Swings Work For You
With the stock market moving around in earnings season, now is the time to look through our buy and sell chart looking for ways to maximize your upside
4 Attractive Biopharma Stocks of All Sizes
Biopharma is a high-growth niche in a defensive sector, but you need to balance risk with reward. Here are four hot biopharma stocks of different sizes.
9 Biotech Buyout Players to Watch
The deal between Human Genome Sciences and GlaxoSmithKline is just the most recent of big pharma buyouts -- and these biotech players could be next.
Top 6 Stocks to Buy for July
This month’s emphasis is on stocks that should do well despite near-term market concerns.
7 Biotech Stocks to Add to Your Portfolio
The biotech business is working overtime to find the next breakthrough drugs and treatments for a population that gets older every day.
7 Biotech Stocks to Buy
With an aging U.S. population in need of healthcare, biotech stocks will grow with the demographic, providing an excellent chance to buy these 7 stocks.
6 Semiconductor Stocks to Satisfy Your Inner Geek
These popular semiconductor stocks rank among the many tech stocks considered buys and strong buys.
Amazon Skewered After Hours — Tuesday’s IP Market Recap
And Netflix, RadioShack got beat up during the day.
10 Chipmakers With Big Returns
These 10 companies may create tiny chips, but over the past year they have been seeing very big returns.
RIMM Completes a Week of Gloomy Outlooks — Friday’s IP Market Recap
Research In Motion joined Intel, Best Buy and First Solar in forecasting leaner times ahead. Here's a look at RIM, as well as other big news from this week.
Merck CEO Pledges Drug Pipeline Will Yield Results in Both Short and Long Term
Merck CEO Kenneth Frazier acknowledges company's lagging stock, touts potential of numerous drugs in late development stages.
